FI924045A0 - Genexpressionssystem. - Google Patents

Genexpressionssystem.

Info

Publication number
FI924045A0
FI924045A0 FI924045A FI924045A FI924045A0 FI 924045 A0 FI924045 A0 FI 924045A0 FI 924045 A FI924045 A FI 924045A FI 924045 A FI924045 A FI 924045A FI 924045 A0 FI924045 A0 FI 924045A0
Authority
FI
Finland
Prior art keywords
gene
phibacin
mutant
genexpressionssystem
expression
Prior art date
Application number
FI924045A
Other languages
English (en)
Other versions
FI924045A (fi
Inventor
David J Mcconnell
Kevin M Devine
Charles O'kane
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI924045A publication Critical patent/FI924045A/fi
Publication of FI924045A0 publication Critical patent/FI924045A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/75—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Bacillus

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI924045A 1990-03-11 1992-09-10 Genexpressionssystem. FI924045A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE289389A IE892893A1 (en) 1990-03-11 1990-03-11 Phage-like bacteriocins
PCT/DK1991/000074 WO1991013990A1 (en) 1990-03-11 1991-03-11 A gene expression system

Publications (2)

Publication Number Publication Date
FI924045A FI924045A (fi) 1992-09-10
FI924045A0 true FI924045A0 (fi) 1992-09-10

Family

ID=11036947

Family Applications (1)

Application Number Title Priority Date Filing Date
FI924045A FI924045A0 (fi) 1990-03-11 1992-09-10 Genexpressionssystem.

Country Status (9)

Country Link
US (1) US5843702A (fi)
EP (1) EP0520004B1 (fi)
AT (1) ATE185165T1 (fi)
AU (1) AU651966B2 (fi)
CA (1) CA2078009A1 (fi)
DE (1) DE69131665T2 (fi)
FI (1) FI924045A0 (fi)
IE (1) IE892893A1 (fi)
WO (1) WO1991013990A1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516682A (en) * 1988-07-05 1996-05-14 University Of Maryland Subtilin variant of enhanced stability and activity
JPH11507532A (ja) * 1995-06-07 1999-07-06 ワシントン ユニバーシティ 環境に制限される生存能を有する組換え細菌システム
US7160711B2 (en) * 2001-08-06 2007-01-09 Degussa Ag Coryneform bacteria which produce chemical compounds I
US8124399B2 (en) 2002-03-29 2012-02-28 Danisco Us Inc. Enhanced protein expression in Bacillus
US9200251B1 (en) 2011-03-31 2015-12-01 David Gordon Bermudes Bacterial methionine analogue and methionine synthesis inhibitor anticancer, antiinfective and coronary heart disease protective microcins and methods of treatment therewith

Also Published As

Publication number Publication date
EP0520004B1 (en) 1999-09-29
AU7544991A (en) 1991-10-10
FI924045A (fi) 1992-09-10
EP0520004A1 (en) 1992-12-30
ATE185165T1 (de) 1999-10-15
US5843702A (en) 1998-12-01
WO1991013990A1 (en) 1991-09-19
CA2078009A1 (en) 1991-09-12
DE69131665D1 (en) 1999-11-04
DE69131665T2 (de) 2000-06-08
IE892893L (en) 1989-09-11
IE892893A1 (en) 1991-09-25
AU651966B2 (en) 1994-08-11

Similar Documents

Publication Publication Date Title
ATE274353T1 (de) Verwendung von aufgereinigtem invaplex als impfstoff für gram-negativebakterien
ATE152172T1 (de) Herstellung eines rekombinanten menschlichen interleukin-1-hemmers
NO951198D0 (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
DK0816378T3 (da) Antibiotiske glycopeptidamidderivater
FI960977A0 (fi) Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet
FI943389A0 (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
HUP9900935A2 (hu) Baktériumellenes és gombaellenes hatású peptid és eljárás az előállítására
DE3683267D1 (de) Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung.
SE9101838D0 (sv) Novel peptides and their use
ATE185165T1 (de) Gen-expressionssystem
DK165120C (da) Basiske monokarboxyamidderivater af actagardin, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater indeholdende derivaterne
DE58908428D1 (de) Sekretormutante von Escherichia coli.
ES2170251T3 (es) (s)-hidroxinitriloliasa de hevea brasiliensis.
CA2111083A1 (en) Novel peptides, their preparation and use
SE8500093D0 (sv) Urokinasderivat urokinasderivat
ATE214098T1 (de) Neue cephalosporin-c-acylase
PT852497E (pt) Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas
FR2661188B1 (fr) Nouveaux vecteurs de clonage et/ou d'expression, procede de preparation et leur utilisation.
SE9403636D0 (sv) Vaccine preparation
WO1994021273A3 (de) VERWENDUNG VON ANGIOGENIN UND/ODER α1-MICROGLOBULIN UND/ODER KOMPLEMENTFAKTOR D ZUR BEGRENZUNG DER SEKRETION VON PROTEINEN
RU94003337A (ru) Штамм бактерий morganella morganii - продуцент термолабильного энтеротоксина
KR970009339B1 (en) Tpa from scolopendra subepinpes multilans and its purification method
ATE132186T1 (de) Verfahren zur inaktivierung von viren
RU95107329A (ru) Тиомаринол с и способ его получения
IT1276765B1 (it) Gene del cromosoma x umano e proteina codificata da detto gene.